ORIGINAL PAPERS |
|
Kotenko O.N., Abolyan L.V., Kuteinikov V.Yu., Vinogradov V.E., Dorofeeva E.G.
Analysis of satisfaction with drug therapy for anemia in patients with stage 5 chronic kidney disease on hemodialysis
|
5-12 |
Zhmurov D.V., Zhmurov V.A., Petrov I.M., Petelina T.I., Gapon L.I., Yaroslavskaya E.I., Petrova Yu.A., Reshetnikova T.V., Tolstoukhova N.V., Zhmurova E.A., Ermakova A.A., Ermakova P.A.
Dynamic monitoring of the cardiovascular system and kidney function in patients with chronic kidney disease who had COVID-19
|
13-18 |
Komissarov K.S., Nizheharodava D.B., Minchenko E.I., Ivanchik G.I., Pilotovich V.S., Zafranskaya M.M.
The effectiveness of hydroxychloroquine and its effect on cell-mediated and humoral immunity in patients with immunoglobulin A nephropathy: results of a prospective controlled study
|
19-26 |
NEPHROUROLOGY |
|
Lubennikov A.E., Trushkin R.N., Berezhnaya E.E., Isaev T.K., Morozov N.V., Medvedev P.E., Kolesnikov N.O.
Renal cell carcinoma in patients receiving hemodialysis treatment
|
27-32 |
Trushkin R.N., Medvedev P.E., Isaev T.K., Klementieva T.M., Morozov N.V., Ivanov K.V.
Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease
|
33-42 |
LITERATURE REVIEWS |
|
Bobkova I.N., Kamyshova E.S.
Therapy for immunoglobulin А-nephropathy: what along with immunosuppression?
|
43-48 |
Bachmakov I.E., Fedoseev A.N., Denisova V.E.
Insulin resistance in chronic kidney disease
|
49-58 |
PAGES OF HISTORY |
|
Morgoshiia T.Sh., Turabova N.M.
In memory of the great clinician-innovator and humanist academician of the USSR Academy of medical sciences Vladimir Kharitonovich Vasilenko (1897–1987). To the 125th anniversary of the scientist’s birth
|
59-63 |
GUIDELINE |
|
Philip Kam-Tao Li, Kai Ming Chow, Yeoungjee Cho, Stanley Fan, Ana E Figueiredo, Tess Harris, Talerngsak Kanjanabuch, Yong-Lim Kim, Magdalena Madero, Jolanta Malyszko, Rajnish Mehrotra, Ikechi G Okpechi, Jeff Perl, Beth Piraino, Naomi Runnegar, Isaac Teitelbaum, Jennifer Ka-Wah Wong, Xueqing Yu , David W Johnson
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
|
64-99 |